J&J diabetes drug shows heart benefit in large safety study – Reuters
Reuters |
J&J diabetes drug shows heart benefit in large safety study
Reuters FILE PHOTO – A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017. REUTERS/Mike Blake/File Photo. By Bill Berkrot. Johnson & Johnson’s type 2 diabetes drug Invokana significantly reduced the risk of serious heart problems … J&J Drug Prevents Heart Attacks At Cost Of Amputated Toes CANVAS: Canagliflozin Reduces CV Events, but at Cost of Amputations Canagliflozin reduces risk for CVD, kidney disease in patients with type 2 diabetes |
View original article
Author:
Powered by WPeMatico
Health Topic Contributor
Editors and curators bringing you the latest and most impactful health news. Truly objective, we print links to stories and studies that may contradict one another. If you're searching for news on health studies, alternative health modalities, facts on modern allopathic medicine, and more, we're you're team bringing you the stories and facts that matter.